Sunitinib Malate and Hydroxychloroquine in Treating Patients With Advanced Solid Tumors That Have Not Responded to Chemotherapy
Clinical trial NCT00813423 · COMPLETED
Trial details
- NCT number
- NCT00813423
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-02-19
- Primary completion
- 2023-07-18
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.